Elaine Hsiao,Wei-Li Wu,Sarkis K. Mazmanian,Paul H. Patterson
申请号：
US14925240
公开号：
US20160120916A1
申请日:
2015.10.28
申请国别(地区):
US
年份:
2016
代理人:
摘要：
Some embodiments include probiotics for use in treatment of one or more autism spectrum disorder (ASD) or epilepsy in a subject in need thereof. The probiotics can comprise Bacteroides bacteria (e.g., B. fragilis). In some embodiments, the subject is identified in need of treatment ASD or epilepsy based a combination of behavioral symptoms and optional genetic markers. Upon treatment, one or more ASD-related behaviors are improved in the subject.
